News & Analysis as of

Food and Drug Administration (FDA) › Revocation

Faegre Drinker Biddle & Reath LLP

FDA’s Revocation of the Hydroxychloroquine and Chloroquine EUA May Test the Limits of PREP Act Immunity

Faegre Drinker Biddle & Reath LLP on

On June 15, 2020, the U.S. Food & Drug Administration (FDA) revoked the Emergency Use Authorization (EUA) that permitted emergency distribution of chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ) from the...more

Searcy Denney Scarola Barnhart & Shipley

FDA Takes Strong Action to Protect Patients — Breast Institute at JFK Medical Center

Searcy Denney Scarola Barnhart & Shipley on

West Palm Beach, Florida - The US Food and Drug Administration (FDA), has recently taken the extraordinary step of requiring The Breast Institute at the JFK Medical Center North, located at 2201 45th Street in West Palm...more

Faegre Drinker Biddle & Reath LLP

Court Finds FDA Explanation of Knee Implant Reversal Lame

Faegre Drinker Biddle & Reath LLP on

The FDA had approved the mesh—called the Collagen Scaffold—in December 2008. But after the change in administrations the following month, the agency decided that the approval process had been flawed and had been the focus of...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide